XOFLUZA gran 2 mg/ml pour susp fl 20 ml
7680680680018
CH-68068
J05AX25
08.03.0.
1 / 3
google
Details
- Product number
- 6806801
- CPT
- -
- Packaging group
- 1
- Unit
- Flasche(n)
- Composition
- baloxavirum marboxilum 40 mg, mannitolum, maltitolum 700 mg, natrii chloridum corresp. natrium 23.59 mg, hypromellosum, povidonum K 25, silica colloidalis anhydrica, sucralosum, talcum, aromatica (Erdbeer) ad granulatum pro 2 g.
Articles (1)
Xofluza 2 mg / ml, Granulat zur Herstellung einer Suspension zum Einnehmen (Flasche)
Granulat
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
baloxavirum marboxilum
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
mannitolum
|
- | Substance | HNIDK |
|
maltitolum
|
700.0 MG | Substance | HBESI |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
23.59 MG | Substance | HBESI |
|
hypromellosum
|
- | Substance | HNIDK |
|
povidonum K 25
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
sucralosum
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 68068
- Drug name
- Xofluza, Granulat zur Herstellung einer Suspension zum Einnehmen
- Galenic form
- GRAS
- ATC Code
- J05AX25
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/11/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XOFLUZA gran 2 mg/ml pour susp fl 20 ml
- Description (DE)
- XOFLUZA Gran 2 mg/ml für Susp Fl 20 ml
- Market launch
- 19/11/2021
- Narcotic (BTM)
- No